Publikationen 2019

  • Kalke J, Haug S, Hayer T. Glücksspiele und Glücksspielsucht im Alter: Ein kursorischer Forschungsüberblick. Suchtmagazin; 45: 33-37
  • Reiß M, Schulte B, Schmidt CS, Carstens A, Görne H, Kreibich R, Tietje W, Weber B, Schnell T, Verthein U (2019) Selbst- und Fremdbeurteilung von Depressivität bei opioidabhängigen Patienten in Substitutionsbehandlung. Suchttherapie, DOI: 10.1055/a-1032-6735
  • Kilian C, Manthey J, Moskalewicz J, Sieroslawski J, Rehm J (2019) How Attitudes toward Alcohol Policies Differ across European Countries: Evidence from the Standardized European Alcohol Survey (SEAS). Int. J Environ Res Public Health; 16: 4461. doi:10.3390/ijerph16224461
  • Manthey J, Carr S, Rehm J (2019) Definition of a ‘Standard Joint Equivalent’: Comment on “Who consumes most of the cannabis in Canada? Profiles of cannabis consumption by quantity”. Drug and Alcohol Dependence; doi: https://doi.org/10.1016/j.drugalcdep.2019.107731
  • Schulte B, Schmidt CS, Strada L, Rosenkranz M, Schäfer I, Verthein U, Reimer
    J (2019) Hepatitis C Virus Prevalence and Incidence in a Large Nationwide Sample of Patients in Opioid Substitution Treatment in Germany: A Prospective Cohort Study. Clin Infect Dis. doi: 10.1093/cid/ciz661
  • Schulte B, Kaner EFS, Beyer F, Schmidt CS, O'Donnell A (2019) Study protocol for a
    systematic review of evidence for digital interventions for comorbid excessive
    drinking and depression in community-dwelling populations. BMJ Open; 17;9:e031503. doi: 10.1136/bmjopen-2019-031503
  • Buth S, Holzbach R, Martens MS, Neumann-Runde E, Meiners O, Verthein U (2019) Problematic medication with benzodiazepines, “Z-drugs”, and opioid analgesics— an analysis of national health insurance prescription data from 2006–2016. Dtsch Arztebl Int; 116: 607–14. DOI: 10.3238/arztebl.2019.0607
  • O'Donnell A, Anderson P, Jané-Llopis E, Manthey J, Kaner E, Rehm J (2019) Immediate impact of minimum unit pricing on alcohol purchases in Scotland: controlled interrupted time series analysis for 2015-18. BMJ; 25:366 doi:10.1136/bmj.l5274
  • Rehm J, Elton-Marshall T, Sornpaisarn B, Manthey J (2019) Medical marijuana. What can we learn from the experiences in Canada, Germany and Thailand? Int J Drug Policy; 13:74:47-51. doi: 10.1016/j.drugpo.2019.09.001
  • Rehm J, Manthey J, Lange S, Badaras R, Zurlyte I, Passmore J, Breda J,
    Ferreira-Borges C, Štelem?kas M (2019) Alcohol control policy and changes in
    alcohol-related traffic harm. Addiction. doi: 10.1111/add.14796
  • Manthey J, Rehm J (2019) Mortality from Alcoholic Cardiomyopathy: Exploring the Gap between Estimated and Civil Registry Data. J Clin Med; 31: 8. doi:10.3390/jcm8081137
  • Kalke J & Hayer T. Expertise zur Wirksamkeit von Maßnahmen des Spieler- und Jugendschutzes: Ein systematischer Review. In: Becker T, Hrsg. Schriftenreihe zur Glücksspielforschung (Band 21). Berlin: Peter Lang, 2019
  • Milin S, Schäfer I (2019) Methamphetamin-bezogene Störungen: Diagnostik und Therapie. Fortschritte der Neurologie – Psychiatrie 87, 385–398
  • Lotzin A, Schäfer I (2019) Diagnostik der Komplexen Posttraumatischen Belastungsstörung. Trauma und Gewalt, 13, 20-27
  • Schneider B, Eilert L, Milin S, Schäfer I (2019) Suizidalität bei Abhängigkeit von illegalen Substanzen und psychotrop wirksamen Medikamenten. Suchttherapie. 20: 129-134. doi: 10.1055/a-0947-2975
  • Milin S, Schneider B, Eilert L, Schäfer I (2019) Suizidalität bei Suchtkranken – Erfahrungen, Kenntnisse und Fortbildungsbedarfe bei Fachkräften der Suchthilfe. Suchttherapie. 20: 144 – 149. doi: 10.1055/a-0944-8107
  • Manthey J (2019) Cannabis use in Europe: Current trends and public health concerns.
    Int J Drug Policy;68:93-96. doi: 10.1016/j.drugpo.2019.03.006. 
  • Verthein U, Buth S, Holzbach R, Neumann-Runde E, Martens MS (2019) Benzodiazepines and Z-Drugs - Analyses of Ambulatory Prescriptions from 2006 to 2015. Psychiatr Prax. doi: 10.1055/a-0961-2371
  • Rosenkranz M, O'Donnell A, Uwe Verthein U, Zurhold H, Addison M, Liebregts N, Rowicka M, Barták M, Petruželka B, Kaner E, Martens M (2019) Understanding pathways to stimulant use: a mixed-methods examination of the individual, social and cultural factors shaping illicit stimulant use across Europe (ATTUNE): study protocol. BMJ Open 9:e029476. doi:10.1136/ bmjopen-2019-029476
  • Schneider U, Schäfer I, Hillemacher T, Cimander KF, Wedekind D, Weirich S, Havemann-Reinecke U (2019) Opioid maintenance treatment and Cannabis use. Fortschr Neurol Psychiatr. doi: 10.1055/a-0918-5961
  • Thomas S, Höfler M, Schäfer I, Trautmann S (2019) Childhood maltreatment and treatment outcome in psychotic disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. doi: 10.1111/acps.13077 
  • Lotzin A, Buth S, Sehner S, Hiller P, Pawils S, Metzner F, Read J, Härter M, Schäfer I (2019) Reducing barriers to trauma inquiry in substance use disorder treatment a cluster-randomized controlled trial. Subst Abuse Treat Prev Policy. 29; 14:23. doi: 10.1186/s13011-019-0211-8
  • Manthey J, Rehm J (2019) Mortality from Alcoholic Cardiomyopathy: Exploring the Gap between Estimated and Civil Registry Data. J Clin Med. 31;8. doi: 10.3390/jcm8081137
  • Holzbach R, Stammen G, Kirchhof U, Scherbaum N (2019) The Prescription of Anticraving Medication and its Economic Consequences. Eur Addict Res;25(5):224-228. doi: 10.1159/000500521
  • Scherbaum N, Holzbach R, Stammen G, Kirchof U, Bonnet U (2019) Very Low Frequency of Drug Therapy of Alcohol Dependence in Germany - Analysis of Data of A Statutory Health Insurance. Pharmacopsychiatry; doi: 10.1055/a-0896-2757
  • Manthey J, Shield K, Rylett M, Hasan O, Probst C, Rehm J (2019) Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet, doi: 10.1016/S0140-6736(18)32744-2
  • Manthey J (2019) Cannabis use in Europe: Current trends and public health concerns. International Journal of Drug Policy; 68, 93-96
  • Rehm J, Manthey J, Shield KD, Ferreira-Borges C (2019) Trends in substance use and in the attributable burden of disease and mortality in the WHO European Region, 2010-2016. European Journal of Public Health, doi: 10.1093/eurpub/ckz064
  • Schäfer I, Lotzin A, Hiller P, Sehner S, Driessen M, Hillemacher T, Schäfer M, Scherbaum N, Schneider B & Grundmann J (2019) A multisite randomized controlled trial of Seeking Safety vs. Relapse Prevention Training for women with co-occurring posttraumatic stress disorder and substance use disorders. European Journal of Psychotraumatology; 10:1577092
  • Reimer J, Kuhn J, Wietfeld R, Janetzky W, Leopold K (2019) Motivational interviewing: A possibility for doctor-patient communication in schizophrenia? Nervenarzt. doi: 10.1007/s00115-019-0702-x
  • Hayer T, Rosenkranz M, Meyer G, Brosowski T (2019). Simuliertes Glücksspiel im Internet Ergebnisse einer quantitativen Befragung von Schülern und Schülerinnen zu Konsummustern und Risikobedingungen. Kindheit und Entwicklung; doi: 10.1026/0942-5403/a000275
  • Kalke J & Buth S (2019) Kognitive Verzerrungen bei türkeistämmigen pathologischen Glücksspielern. In: Wöhr A, Wuketich M, Hrsg. Multidisziplinäre Betrachtung des vielschichtigen Phänomens Glücksspiel. Wiesbaden: Springer VS; 429-47
  • Fegert JM, Baumeister H, Brieger P, Gallinat J, Grabe HJ, Gündel H, Härter M, Oexle N, Prestin E, Rassenhofer M, Riedel-Heller SG, Rüsch N, Schäfer I, Schomerus G, Schulz H, Speck A, Steinhart I, Stengler K, Becker T (2019) Mental Health Research - "Lost in Translation?" Psychiatr Prax. 46:70-72. doi: 10.1055/a-0851-5216
  • Christensen S, Buggisch P, Mauss S, Böker KH, Müller T, Klinker H, Zimmermann T, Serfert Y, Weber B, Reimer J, Wedemeyer H; German Hepatitis C-Registry (2019) Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy-Data From the German Hepatitis C-Registry (DHC-R). Subst Abuse. 28; 13:1. doi: 10.1177/1178221819835847
  • Kraus L, Seitz NN, Schulte B, Cremer-Schaeffer P, Braun B, Verthein U, Pfeiffer-Gerschel T (2019) Schätzung der Anzahl von Personen mit einer Opioidabhängigkeit. Dtsch Arztebl Int 2019; 116: 137–43
  • Mokhar A, Kuhn S, Topp J, Dirmaier J, Härter M & Verthein U (2019) Long-term use of benzodiazepines and z-drugs: a qualitative study of patients’ and health care professionals’ perception and possible levers for change. BJGP Open. doi: 10.3399/bjgpopen18X101626.
  • Schellong J, Hanschmidt F, Ehring T, Knaevelsrud C, Schäfer I, Rau H, Dyer A, Krüger-Gottschalk A (2019) Diagnostik der PTBS im Spannungsfeld von DSM-5 und ICD-11. Nervenarzt; doi: 10.1007/s00115-018-0668-0
  • Melchior H, Hüsing P, Grundmann J, Lotzin A, Hiller P, Pan Y, Driessen M, Scherbaum N, Schneider B, Hillemacher T, Stolzenburg S, Schomerus G, Schäfer I; Cansas Study Group (2019) Substance Abuse-Related Self-Stigma in Women with Substance Use Disorder and Comorbid Posttraumatic Stress Disorder. Eur Addict Res; 25:20-29
  • Gidzgier P, Grundmann J, Lotzin A, Hiller P, Schneider B, Driessen M, Schäfer M, Scherbaum N, Hillemacher T, Schäfer I (2019) The dissociative subtype of PTSD in women with substance use disorders: Exploring symptom and exposure profiles. Journal of Substance Abuse Treatment. Journal of Substance Abuse Treatment; 99: 73-79 DOI: 10.1016/j.jsat.2019.01.004
  • Langner I, Haug U, Scholle O, Lindemann C, Schröder C, Riedel O (2019) Potential explanations for increasing methylphenidate use in children and adolescents with Attention-Deficit/Hyperactivity Disorder in Germany from 2004 to 2013. J Clin Psychopharmacol; 39: 39-45
  • Strada L, Schmidt CS, Rosenkranz M, Verthein U, Scherbaum N, Reimer J, Schulte B (2019) Factors associated with health-related quality of life in a large national sample of patients receiving opioid substitution treatment in Germany: A cross-sectional study. Substance Abuse Treatment, Prevention, and Policy; 14:2
  • Heddaeus D, Dirmaier J, Daubmann A, Grochtdreis T, König HH, Löwe B, Maehder K, Porzelt S, Rosenkranz M, Schäfer I, Scherer M, Schulte B, von dem Knesebeck O, Wegscheider K, Weigel A, Werner S, Zimmermann T und Härter M (2019). Erprobung eines integrierten und gestuften Behandlungsmodells für psychische Störungen und Komorbiditäten im Hamburger Netzwerk für Versorgungsforschung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. doi:10.1007/s00103-018-2865-1